Sign In
Buy NVS
$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
07:56am, Tuesday, 27'th May 2025
Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer
Are You Looking for a High-Growth Dividend Stock?
12:51pm, Wednesday, 21'st May 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes?
If I Could Only Buy 2 Dividend Stocks Right Now (May 2025 Edition)
07:30am, Tuesday, 20'th May 2025
I've added Novo Nordisk and Novartis to boost The Dividend Income Accelerator's healthcare allocation and global diversification, reducing overall risk and volatility. Both companies are attractively
Here's Why Novartis (NVS) is a Strong Value Stock
10:46am, Friday, 16'th May 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock?
01:05pm, Thursday, 15'th May 2025
Novartis (NVS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy Novartis (NVS) Stock?
10:45am, Thursday, 15'th May 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline
09:00am, Thursday, 15'th May 2025
Basel, May 15, 2025 – Novartis will present data from 60 company or investigator sponsored abstracts that have the potential to change clinical practice, at the 2025 American Society of Clinical Onc
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
12:36pm, Monday, 12'th May 2025
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
12:30pm, Monday, 12'th May 2025
President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly higher (up t
Novartis to keep making malaria drugs if orders dry up amid aid cuts
03:19am, Monday, 12'th May 2025
Swiss drugmaker Novartis will keep making medicines for malaria and leprosy, even if it does not get orders as normal amid the global health funding crunch, its president of global health told Reuters
Here's Why Novartis (NVS) is a Strong Momentum Stock
10:55am, Friday, 09'th May 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Pressure is still on the pharma sector, says Mizuho's Jared Holz
07:23pm, Thursday, 08'th May 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.
BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion
03:49pm, Monday, 05'th May 2025
BioNTech SE BNTX on Monday reported a first-quarter per-share loss of $1.82 (1.73 euros), up from 1.31 euros reported a year ago compared to beating the consensus of $2.02.
Novartis (NVS) is a Great Momentum Stock: Should You Buy?
01:05pm, Monday, 05'th May 2025
Does Novartis (NVS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Novartis (NVS) is a Great Dividend Stock Right Now
12:50pm, Monday, 05'th May 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes?
